National Bank of Canada
HUMA icon

National Bank of Canada’s Humacyte HUMA Stock Holding History

National Bank of Canada’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$1.09K – 3224
2026
Q1 		$1.09K Buy
+18
New +$19 ﹤0.01% 2667
2025
Q3 		– Sell
-6,532
Closed -$1.37M – 3016
2025
Q2 		$1.37M Sell
6,532
-1,386
-18% -$2.66K ﹤0.01% 1221
2025
Q1 		$1.35M Buy
+7,918
New +$29.7K ﹤0.01% 1138

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

National Bank of Canada's HUMA Position: Q2 2026 in Review

National Bank of Canada sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 1,800 shares — an estimated $1.09K sold.

National Bank of Canada first reported a position in HUMA in Q3 2024 and held it in 4 quarters. The position peaked at $1.37M in Q2 2025. 72 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • National Bank of Canada reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • National Bank of Canada sold 1,800 Humacyte shares in Q2 2026, an estimated $1.09K.
  • National Bank of Canada first reported a position in Humacyte in Q3 2024 and held it in 4 quarters.
  • National Bank of Canada's Humacyte position peaked at $1.37M in Q2 2025.
  • 72 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.